Ontology highlight
ABSTRACT:
INSTRUMENT(S): LTQ Orbitrap
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Epithelial Cell, Cell Culture
DISEASE(S): Renal Cell Carcinoma
SUBMITTER: Wei-Chi Ku
LAB HEAD: Wei-Chi Ku
PROVIDER: PXD001962 | Pride | 2016-04-26
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
120807ku-05-Est1-Pho-1.raw | Raw | |||
120807ku-07-Est1-Pho-2.raw | Raw | |||
120807ku-09-Est1-Am-1.raw | Raw | |||
120807ku-11-Est1-Am-2.raw | Raw | |||
120807ku-13-Est1-Py-1.raw | Raw |
Items per page: 5 1 - 5 of 22 |
Chen Kuo-Chiang KC Lin Chih-Ming CM Huang Chi-Jung CJ Chen Shao-Kuan SK Wu Sheng-Tang ST Chiang Han-Sun HS Ku Wei-Chi WC
Cancer genomics & proteomics 20160501 3
<h4>Background</h4>It has been proposed that 17-β-estradiol (E2) activates estrogen receptor and inhibits renal cell carcinoma (RCC) growth. In the present study we explored the role of E2 and ER in the regulation of RCC growth.<h4>Materials and methods</h4>The RCC cell line ACHN was treated by E2 combining with E2 antagonist Fulvestrant or ER knockdown, and cell growth was monitored. Quantitative phosphoproteomics was applied to study the E2 regulated non-genomic phosphorylation changes. Wester ...[more]